Core Insights - Hims & Hers Health, Inc. reported 481.14millioninrevenueforQ42024,markingayear−over−yearincreaseof95.10.11, compared to 0.01ayearago,althoughitfellshortoftheconsensusestimateof0.12 by 8.33% [1] - The revenue exceeded the Zacks Consensus Estimate of 471.42millionby2.06168, surpassing the two-analyst average estimate of 158.71[4]−NetOrdersstoodat2.81million,matchingthetwo−analystaverageestimate[4]−MonthlyOnlineRevenueperAverageSubscriberwas73, exceeding the two-analyst average estimate of 71.16[4]−Subscribersattheendoftheperiodtotaled2.23million,belowthetwo−analystaverageestimateof2.38million[4]−RevenuefromWholesalewas10.38 million, slightly above the 10.15millionaverageestimatebasedonfiveanalysts[4]−OnlineRevenuereached470.76 million, surpassing the $460.87 million average estimate based on five analysts [4] Stock Performance - Shares of Hims & Hers Health have returned +59.6% over the past month, contrasting with the Zacks S&P 500 composite's -0.5% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]